News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-21 1:3:42 pm Kineta Reports Full Year 2023 Financial Results and Provides Corporate Update GlobeNewsWire
2024-03-12 5:0:0 am KVA12123 Clears Additional Cohorts in Monotherapy and in Combination Therapy Arms in the Phase 1/2 VISTA-101 Clinical Trial; Initial Clinical Response Data Reported GlobeNewswire
2024-02-29 5:30:0 am Kineta Announces Restructuring and Exploration of Strategic Alternatives GlobeNewswire
2024-02-22 5:30:0 am Kineta to Present New Preclinical Data on its Anti-VISTA Antibody KVA12123 in Acute Myeloid Leukemia at the AACR Blood Cancer Discovery Symposium GlobeNewswire
2024-02-14 5:30:0 am Kineta to Present at Upcoming Investor Conferences GlobeNewswire
2024-02-07 5:30:0 am Kineta to Participate in H.C. Wainwright Virtual @Home Fireside Chat Series GlobeNewswire
2024-01-29 1:32:0 am KA: Phase I/II Update Zacks Small Cap Research
2024-01-17 5:30:0 am Kineta Provides Update on its Ongoing Phase 1/2 VISTA-101 Clinical Trial of KVA12123 in Patients with Advanced Solid Tumors GlobeNewswire
2024-01-04 5:30:0 am Kineta to Participate in the 13th Annual LifeSci Partners Corporate Access Event GlobeNewswire
   

Please consider a small donation if you think this website provides you with relevant information